文献速递性腺与生殖内分泌垂体与肾上腺疾病

阿片类药物及其内分泌影响:系统综述与荟萃分析

Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

结果显示男性阿片使用者中性腺功能减退症患病率为63%(95%CI:55%-70%),皮质醇功能减退症患病率约为15%(95%CI:6%-28%)。结论建议定期评估至少性腺和肾上腺轴。

要点

  • 男性阿片使用者性腺功能减退症患病率高达63%。
  • 皮质醇功能减退症在全部患者中患病率约为15%。
  • 建议对阿片使用者定期评估性腺和肾上腺轴功能。

核心结论

  • 男性阿片使用者中超过半数发生性腺功能减退症,约五分之一患者发生皮质醇功能减退症。
  • 建议定期评估至少性腺和肾上腺轴。

研究设计与样本

  • 系统综述与荟萃分析,检索8个电子数据库至2018年5月8日。
  • 最常用阿片类药物为美沙酮(13项研究),其次为吗啡(12项研究)。

主要发现

  • 性腺功能减退症患病率为63%(95%CI:55%-70%,15项研究,3250名患者,99.5%为男性)。
  • 基于动态和非动态测试的皮质醇功能减退症患病率为15%(95%CI:6%-28%,5项研究,205名患者,57.5%为男性)。
  • 仅纳入胰岛素耐受试验的研究中皮质醇功能减退症患病率为24%(95%CI:16%-33%,2项研究,97名患者)。
  • 7项研究中有5项存在高泌乳素血症。
  • 未描述对生长激素轴和下丘脑-垂体-甲状腺轴有明确影响。

临床怎么用

  • 对长期使用阿片类药物的患者,应定期评估性腺轴和肾上腺轴功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The increased use of opioids has resulted in an unprecedented opioid epidemic. Chronic opioid use causes hypogonadism, but its frequency, as well as the effects of opioids on other hypothalamo-pituitary-end organ hormone axes, remains unclear. OBJECTIVE: The aim of this systematic review and meta-analysis was to assess the effects of opioid use on pituitary function. METHODS: Eight electronic databases were searched for articles published up to May 8, 2018. Fixed or random effects meta-analysis was performed to estimate pooled proportions with 95% confidence intervals (CI). This study is reported following the PRISMA and MOOSE guidelines. DATA SYNTHESIS: 52 studies (22 low risk of bias) were included describing 18 428 subjects, consisting of patients with chronic pain (n = 21 studies) or on maintenance treatment for opioid addiction (n = 9) and healthy volunteers (n = 4). The most frequently used opioid was methadone (n = 13 studies), followed by morphine (n = 12). Prevalence of hypogonadism was 63% (95% CI: 55%-70%, 15 studies, 3250 patients, 99.5% males). Prevalence of hypocortisolism relying on dynamic and nondynamic testing was 15% (95% CI: 6%-28%, 5 studies, 205 patients, 57.5% males) and including only studies using the insulin tolerance tests 24% (95% CI 16%-33%, 2 studies, n = 97 patients). In 5 out of 7 studies, hyperprolactinemia was present. No clear effects on the somatotropic and hypothalamo-pituitary-thyroid axes were described. CONCLUSIONS: Hypogonadism occurs in more than half of male opioid users, and hypocortisolism in approximately one-fifth of all patients. Periodical evaluation of at least the gonadal and adrenal axes is therefore advisable.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. de Vries F, Bruin M, Lobatto DJ, et al. Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2020. PMID: 31511863. doi:10.1210/clinem/dgz022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。